FDA Begins Review of Alnylam's SNDA for Expanded Amvuttra Use

Zacks Nov 26 08:35 ET

Scotiabank Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $310

Moomoo NewsNov 26 08:32 ET · Ratings

Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $280

Moomoo NewsNov 26 08:32 ET · Ratings

Scotiabank Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TipRanksNov 26 07:36 ET · Ratings

CCORF Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $384

Moomoo NewsNov 26 07:34 ET · Ratings

Alnylam Pharmaceuticals: Strategic Positioning and Growth Opportunities Reinforce Buy Rating Amidst Competitive ATTR-CM Market

TipRanksNov 26 07:15 ET · Ratings